Botulinum neurotoxin type A — or Botox — may reduce responses to an inflammation-related pain stimulus when injected into the spine, following a study that showed positive effects on mice, published in the Jan. 2011 issue of Anesthesia & Analgesia.
The researchers injected a chemical called formulin into the mouse's paw, causing a predictable two-phase inflammatory pain response. One spinal injection of Botulinum was shown to reduce pain, and mice receiving the injection exhibited significantly fewer pain-related behaviors. The mice also showed no adverse effects on spinal cord function.
Botulinum has been used to successfully treat other chronic pain syndromes, such as headaches and lower back pain, over the past ten years.
Read the study on Botox injections in Anesthesia & Analgesia.
Read more on anesthesia:
-FDA Accepts Drug Application for Postsurgical Pain Management
-Short-Acting Opioids May Increase Fracture Risk in Elderly Patients
-Screening, Drug Reduction Essential for Ambulatory Surgery of Very Old and Very Young Patients
The researchers injected a chemical called formulin into the mouse's paw, causing a predictable two-phase inflammatory pain response. One spinal injection of Botulinum was shown to reduce pain, and mice receiving the injection exhibited significantly fewer pain-related behaviors. The mice also showed no adverse effects on spinal cord function.
Botulinum has been used to successfully treat other chronic pain syndromes, such as headaches and lower back pain, over the past ten years.
Read the study on Botox injections in Anesthesia & Analgesia.
Read more on anesthesia:
-FDA Accepts Drug Application for Postsurgical Pain Management
-Short-Acting Opioids May Increase Fracture Risk in Elderly Patients
-Screening, Drug Reduction Essential for Ambulatory Surgery of Very Old and Very Young Patients